Objective A large-scale retrospective study was conducted on hospital inpatients to evaluate the relationship between community-acquired pneumonia (CAP) and HTLV-I infection. 
Introduction

Human T lymphotropic virus type I (HTLV-I), a retrovirus endemic in the Caribbean region and southwestern Japan, is the etiological agent of adult T-cell leukemia (ATL) (1, 2). In addition, HTLV-I also causes HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) (3) and is associated with other clinical conditions including uveitis
, arthropathy (5) , and bronchopulmonary disorders (6, 7) .
Bronchopulmonary disorders in HTLV-I patients were first reported in HAM/TSP patients (6). Later, Maruyama et al reported that bronchopulmonary disorders are observed not only in HAM/TSP patients, but also in healthy HTLV-I carriers, and proposed the new clinical entity HTLV-Iassociated bronchopneumonopathy (HAB) (8). Other reports have suggested that not only ATL and HAM/TSP patients, but also HTLV-I carriers, have various immunological disorders (9-12).infections and HTLV-I infection. Against this background, a retrospective case-control inpatient study was conducted to examine the prevalence of HTLV-I infection in communityacquired pneumonia (CAP) patients, and to evaluate whether HTLV-I infection has an influence on the manifestation and severity of CAP.
Subjects, Materials, and Methods
Patients for evaluation
The present study included 4,666 
Assay to detect HTLV-I infection
On admission, the levels of serum antibodies to HTLV-I in all patients were measured using the gelatin particle agglutination method. 
Microbiological evaluation
Severity assessment score
The PORT score (18) 
Results
Prevalence of HTLV-I infection
Of the 313 CAP patients in the study [ 
Clinical characteristics of HTLV-I-positive CAP patients
The 59 HTLV-I-positive patients were significantly older than HTLV-I-negative patients (67.8±12. 6 T a b l e 3 . Mu l t i v a r i a t e An a l y s e s o f Ri s k F a c t o r s f o r Co mmu n i t ya c q u i r e d P n e u mo n i a Fig. 1A] , and p =0.008 for the CURB-65 score [Fig. 1B T a b l e 4 . E t i o l o g y o f Co mmu n i t y -a c q u i r e d P n e u mo n i a a mo n g 
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T a b l e 2 . Cl i n i c a l Ch a r a c t e r i s t i c s o f Co mmu n i t y -a c q u i r e d P n e u mo n i a I n p a t i e n t s and eight with RA, two with SjS, and one with systemic lupus erythematosus among the HTLV-I-negative patients. Among the 11 HTLV-I-positive patients with collagen vas-
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3.5%,
]). Even when ATL patients and Pneumocystis pneumonia patients were excluded, both scores were significantly higher in HTLV-I-positive patients (p =0.03 for the PORT score and p =0.004 for the CURB-65 score).
Pathogens causing CAP
S. pneumoniae and Hemophilus influenzae were the most frequently isolated microorganisms in both HTLV-I-positive and HTLV-I-negative groups. The third most frequent organism was P. jiroveci in HTLV-I-positive patients and
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smoldering-type ATL soon afterwards. He had a cough for two weeks and was admitted because of worsening dyspnea. The patchy ground glass opacity and partially dense consolidation was seen on chest CT, and β-D glucan was 256 pg/ mL. The diagnosis of Pneumocystis pneumonia was made by demonstration of Pneumocystis cysts in a BAL smear by Toluidine blue O stain. He was treated by ST and steroid. His hypoxia was prolonged and required ST dosing period of more than 3 weeks; eventually his respiratory condition and CT findings improved.
Klebsiella pneumoniae tended to be more frequent in HTLV-I-positive patients, but the difference was not significant (Table 4) . When the ATL patients were excluded, there were no significant differences in the incidences of each of the pathogens studied (data not shown). (16) , old tuberculosis (14) , tuberculosis (13) , leprosy (13) , chronic renal failure (13) , autoimmune diseases (13) , and strongyloidiasis (13, 15) . Okinawa is an endemic area and the infection rate of HTLV-I in Okinawa is reported to be about 6-20%, differing among districts (20) (21) (22) . In the present study, CAP patients had a higher incidence of HTLV-I infection compared with all inpatients, and HTLV-I carrier patients showed an increased risk of CAP, as did ATL patients. 
Discussion
HTLV-I infection is associated with an increased risk of urinary tract infection
The prevalence of renal diseases and collagen vascular disorders was higher in HTLV-I-positive CAP patients than in HTLV-
